Evidence map›Paper›PMID 39040880›Full record

ArticleHealth science reports2024

A validity and reliability evaluation of fear of progression questionnaire in Iranian breast cancer patients: A methodological study.

Hamid Sharif-Nia, Pooria Sobhanian, Erika Sivarajan Froelicher, Bahar Farhadi, Sima Hejazi, Amir Hossein Goudarzian, Mobin Mohamadinezhad, Ehsan Zaboli, Mohammad Mohsen Hosseinian, Maryam Hasannezhad Reskati and 1 more

Abstract read
In one paragraph

Article in Health science reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hamid Sharif-NiaOrthopedic Research Center Mazandaran University Of Medical Sciences Sari Iran.
Pooria SobhanianStudent Research Committee, Faculty of Medicine Mazandaran University of Medical Sciences Sari Iran.
Erika Sivarajan FroelicherDepartment of Physiological Nursing, School of Nursing, and Department of Epidemiology & Biostatistics, School of Medicine University of California Sand Francisco California San Francisco USA.
Bahar FarhadiSchool of Medicine, Islamic Azad University Mashhad Branch Mashhad Iran.
Sima HejaziBojnurd Faculty of Nursing North Khorasan University of Medical Sciences Bojnurd Iran.
Amir Hossein GoudarzianStudent Research Committee Mazandaran University of Medical Sciences Sari Iran.ORCID 0000-0002-3266-101X
Mobin MohamadinezhadDepartment of Nursing, Amol Faculty of Nursing and Midwifery Mazandaran University of Medical Sciences Sari Iran.
Ehsan ZaboliGastrointestinal Cancer Research Center, Non-Communicable Diseases Institute Mazandaran University of Medical Sciences Sari Iran.
Mohammad Mohsen HosseinianOrthopedic Research Center Mazandaran University of Medical Sciences Sari Iran.
Maryam Hasannezhad ReskatiPsychosomatic Research Center Mazandaran University of Medical Sciences Sari Iran.
Seyed Hamzeh HosseiniPsychiatry and Behavioral Sciences Research Center, Addiction Institute Mazandaran University of Medical Sciences Sari Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Recognizing the ability to adapt coping mechanisms in response to the unique issues present in various Iranian societies underscores the importance of considering culture and religion when interacting with diverse groups of individuals. The objective of this study was to assess the reliability and validity of the fear of progression questionnaire-short form (FoP-Q-SF) in Iranian breast cancer patients. Methods: In this methodological cross-sectional research design, 400 Iranian breast cancer patients completed the FoP-Q-SF in 2023. We assessed the characteristics, content, and both exploratory and confirmatory construct validity of the measures. To evaluate the reliability and construct validity of the FoP-Q-SF, we calculated Cronbach's Results: The average age of the patients was 49.18 (standard deviation = 16.14) years. The results of exploratory factor analysis revealed that a single-factor structure, specifically the self-efficacy scale, accounted for 65.045% of the total variance. The findings from the confirmatory factor analysis indicated a satisfactory model fit. The reliability analysis indicated that the internal consistency and stability of the measures were acceptable. Conclusion: The short Persian version of the FoP-Q-SF exhibits satisfactory validity and reliability. Thus, we recommend using this questionnaire to assess the fear of disease progression among breast cancer patients in Iran.

Indexed as

cancerfear of progressionIranreliabilityvalidity

Identifiers

PMID39040880
PMCPMC11260877

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.